Partnering
|
“Our focus and passion is to reduce CVD risk. This goal represents the largest commercial opportunity in the life sciences industry. Our NexVas PR platform has a world lead in ApoA-I research and has multiple market opportunities for both acute and chronic based patients. We are in detailed discussions with leading firms to partner this exciting technology.”
|
We are engaged in active outreach to leading life science organizations. Our focus is to welcome the best ideas in science and build effective collaborations of every kind through to corporate licensing and acquisition of our leading technologies. We currently have more than 26 active research collaborations and continue to seek innovative partnering opportunities that provide a strategic fit to strengthen our product portfolio and deliver breakthrough medicines to improve people’s lives.
Business Development Contact
Kenneth Lebioda, Senior VP Business & Corporate Development
Email: ken@resverlogix.com
Phone: 403-254-9252 ext. 227
